Serum endostatin and bFGF as predictive factors in advanced breast cancer patients treated with letrozole.
Alba E, Llombart A, Ribelles N, Ramos M, Fernández R, Mayordomo JI, Tusquets I, Gil M, Barnadas A, Carabante F, Ruiz M, Vera R, Palomero I, Soriano V, González J, Colomer R.
Alba E, et al. Among authors: llombart a.
Clin Transl Oncol. 2006 Mar;8(3):193-9. doi: 10.1007/s12094-006-0010-3.
Clin Transl Oncol. 2006.
PMID: 16648119